[ Price : $8.95]
FDA sends an untitled letter to Pinnacle Biologics, citing promotional videos for cancer therapy Photofrin (porfimer sodium).[ Price : $8.95]
FDA approves Gilead Sciences Trodelvy (sacituzumab govitecan-hziy) for first-line treatment of adults with unresectable locally ad...[ Price : $8.95]
FDA says it will not accept medical device test data generated by CCIC Huatongwei International Inspection in China because the ag...[ Price : $8.95]
Speaking at the BIO 2026 convention, former FDAers criticize the informal way in which agency policy was made and announced under ...[ Price : $8.95]
Sen. Tom Cotton (R-AR) introduces a bill that would require FDA to review and potentially recall Chinese-manufactured networked me...[ Price : $8.95]
CeleCor Therapeutics says it has submitted an NDA for Disaggpro (zalunfiban), an investigational treatment for ST-segment elevatio...[ Price : $8.95]
The FY2025 FDA Report on the State of Pharmaceutical Quality shows increased quality assurance inspections over FY 2024.[ Price : $8.95]
A newly published commentary in the journal Stem Cell Research & Therapy says FDAs efforts to reduce reliance on animal testing is...